CA2463578A1 - Differentially expressed genes associated with obesity and type 2 diabetes - Google Patents
Differentially expressed genes associated with obesity and type 2 diabetes Download PDFInfo
- Publication number
- CA2463578A1 CA2463578A1 CA002463578A CA2463578A CA2463578A1 CA 2463578 A1 CA2463578 A1 CA 2463578A1 CA 002463578 A CA002463578 A CA 002463578A CA 2463578 A CA2463578 A CA 2463578A CA 2463578 A1 CA2463578 A1 CA 2463578A1
- Authority
- CA
- Canada
- Prior art keywords
- agt
- seq
- nucleotide sequence
- nucleic acid
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Plant Pathology (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33014901P | 2001-10-16 | 2001-10-16 | |
US60/330,149 | 2001-10-16 | ||
PCT/AU2002/001405 WO2003033513A1 (en) | 2001-10-16 | 2002-10-16 | Differentially expressed genes associated with obesity and type 2 diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2463578A1 true CA2463578A1 (en) | 2003-04-24 |
Family
ID=23288511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002463578A Abandoned CA2463578A1 (en) | 2001-10-16 | 2002-10-16 | Differentially expressed genes associated with obesity and type 2 diabetes |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1446414A4 (zh) |
JP (1) | JP2005510214A (zh) |
KR (1) | KR20040088019A (zh) |
CN (1) | CN1596264A (zh) |
CA (1) | CA2463578A1 (zh) |
IL (1) | IL161294A0 (zh) |
MX (1) | MXPA04003635A (zh) |
WO (1) | WO2003033513A1 (zh) |
ZA (1) | ZA200402859B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004063218A1 (en) * | 2003-01-13 | 2004-07-29 | Autogen Research Pty Ltd | Obesity-related genes |
DE10352510A1 (de) * | 2003-11-07 | 2005-06-23 | Forschungsinstitut Für Die Biologie Landwirtschaftlicher Nutztiere | Verfahren zur Identifizierung von Wirkstoffen zur Beeinflussung der Körpermasse und des Fettansatzes |
CN1961074A (zh) * | 2003-12-24 | 2007-05-09 | 三星电子株式会社 | 包含与ⅱ型糖尿病有关的单核苷酸多态性的多核苷酸、包含该多核苷酸的微阵列和诊断试剂盒以及使用它们分析多核苷酸的方法 |
US20080105961A1 (en) * | 2004-03-16 | 2008-05-08 | Gregory Royce Collier | Ligands of the Molecule Fit (Agt-121) and their Pharmaceutical Use |
US20100028326A1 (en) * | 2004-12-07 | 2010-02-04 | Ohio University | Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
CN114958875B (zh) * | 2022-05-15 | 2023-08-18 | 赣南师范大学 | 柑橘黄龙病菌内参基因metG筛选和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2780405B1 (fr) * | 1998-06-25 | 2001-12-28 | Centre Nat Rech Scient | Nouveaux recepteurs olfactifs et leurs utilisations |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
-
2002
- 2002-10-16 EP EP02801234A patent/EP1446414A4/en not_active Withdrawn
- 2002-10-16 WO PCT/AU2002/001405 patent/WO2003033513A1/en active Application Filing
- 2002-10-16 CA CA002463578A patent/CA2463578A1/en not_active Abandoned
- 2002-10-16 MX MXPA04003635A patent/MXPA04003635A/es not_active Application Discontinuation
- 2002-10-16 IL IL16129402A patent/IL161294A0/xx unknown
- 2002-10-16 JP JP2003536252A patent/JP2005510214A/ja active Pending
- 2002-10-16 CN CNA028236114A patent/CN1596264A/zh active Pending
- 2002-10-16 KR KR10-2004-7005672A patent/KR20040088019A/ko not_active Application Discontinuation
-
2004
- 2004-04-15 ZA ZA200402859A patent/ZA200402859B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL161294A0 (en) | 2004-09-27 |
KR20040088019A (ko) | 2004-10-15 |
WO2003033513A1 (en) | 2003-04-24 |
ZA200402859B (en) | 2005-01-24 |
EP1446414A1 (en) | 2004-08-18 |
MXPA04003635A (es) | 2004-07-30 |
JP2005510214A (ja) | 2005-04-21 |
EP1446414A4 (en) | 2005-11-23 |
CN1596264A (zh) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080171702A1 (en) | Novel gene and uses therefor | |
US20090143571A1 (en) | Novel genes and their use in the modulation of obesity, diabetes and energy imbalance | |
US20070065915A1 (en) | Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals | |
CA2463578A1 (en) | Differentially expressed genes associated with obesity and type 2 diabetes | |
US20040214188A1 (en) | Gene and uses therefor | |
AU2002227795B2 (en) | Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals | |
US20050232918A1 (en) | Differentially expressed genes associated with obesity and type 2 diabetes | |
WO2003016542A1 (en) | Obesity related genes expressed at least in the hypothalamus | |
NZ530543A (en) | A ligand of the protein "beacon" | |
AU2002332956A1 (en) | Differentially expressed genes associated with obesity and type 2 diabetes | |
AU742651B2 (en) | A novel gene and uses therefor | |
AU774097B2 (en) | A novel regulatory molecule and genetic sequences encoding same | |
AU2002227795A1 (en) | Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals | |
AU2002308412A1 (en) | A gene and uses therefor | |
CA2458849A1 (en) | Obesity related genes expressed at least in the hypothalamus, liver or pancreas | |
NZ520101A (en) | Treatment of obesity with a gene expressed in hypothalamus of obese animals | |
AU2002325644A1 (en) | Obesity related genes expressed at least in the hypotalamus, liver or pancreas | |
AU3946900A (en) | A ligand of the protein "beacon" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |